跳至主要内容
临床试验/JPRN-UMIN000000519
JPRN-UMIN000000519已完成未知

A prospective study:the clinical value of acidosis correction by acetate free biofiltration (AFB) in hemodialysis patients. - A prospective study:the clinical value of acidosis correction by acetate free biofiltration (AFB) in hemodialysis patients.

Showa University of Medicine Department of Nephrology0 个研究点目标入组 30 人开始时间: 2006年11月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)chronic inflammation, malignant disorder, severe respiratory organs and liver disorder, heart failure (2)20 years or older. (3)participating in another clinical trial for 12 weeks or longer. (4)pregnant, during the nursing, possibly pregnant and having the hope of child bearing. (5)judged inappropriate as study subject by the investigator.

研究者

发起方
Showa University of Medicine Department of Nephrology

相似试验

已完成
不适用
Investigation of the clinical significances and the pathological features of the lanthanum deposition at the gastric mucosapatients on hemodialysis
JPRN-UMIN000038929Osaka medical college42
进行中(未招募)
1 期
The Effect of Acadesine on Clinically Significant Adverse Cardiovascular and Cerebrovascular Events in High-Risk Subjects Undergoing Coronary Artery Bypass Graft (CABG) Surgery Using Cardiopulmonary Bypass (Protocol No. P05633): RED-CABG Trial (Reduction in Cardiovascular Events by Acadesine in Subjects Undergoing CABG) - RED-CABG TrialCoronary artery diseaseMedDRA version: 9.1 Level: LLT Classification code 10011078 Term: Coronary artery disease
EUCTR2008-004881-16-DESchering-Plough Research Institute, a Division of Schering Corporation7,500
进行中(未招募)
1 期
The Effect of Acadesine on Clinically Significant Adverse Cardiovascular and Cerebrovascular Events in High-Risk Subjects Undergoing Coronary Artery Bypass Graft (CABG) Surgery Using Cardiopulmonary Bypass: RED-CABG Trial (Reduction in Cardiovascular Events by Acadesine in Subjects Undergoing CABG). - RED CABG TrialCoronary artery diseaseMedDRA version: 9.1 Level: LLT Classification code 10011078 Term: Coronary artery disease
EUCTR2008-004881-16-ITSchering-Plough Research Institute, a Division of Schering Corporation7,500
进行中(未招募)
1 期
The Effect of Acadesine on Clinically Significant Adverse Cardiovascular and Cerebrovascular Events in High-Risk Subjects Undergoing Coronary Artery Bypass Graft (CABG) Surgery Using Cardiopulmonary Bypass (Protocol No. P05633): RED-CABG Trial (Reduction in Cardiovascular Events by Acadesine in Subjects Undergoing CABG) - RED-CABG Trial
EUCTR2008-004881-16-FRSchering-Plough Research Institute, a Division of Schering Corporation7,500
招募中
不适用
Clinical evaluation of Ozone gas efficiency on Tooth sensitivity and Tooth whitening
RBR-6685wtniversidade Estadual do Oeste do Paraná - UNIOESTE